mefloquine has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dow, GS; Hudson, TH; Koenig, ML; Vahey, M | 1 |
| Coakley, KM; Hognason, K; McArdle, JJ; Potian, JG; Sellin, LC | 1 |
2 other study(ies) available for mefloquine and thapsigargin
| Article | Year |
|---|---|
The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro.
Topics: Animals; Antimalarials; Calcium; Embryo, Mammalian; Endoplasmic Reticulum; Fetus; Homeostasis; Mefloquine; Microscopy, Confocal; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Prosencephalon; Rats; Stress, Physiological; Thapsigargin; Transcription, Genetic; Up-Regulation | 2003 |
Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals.
Topics: Acetylcholine; Action Potentials; Animals; Antimalarials; Calcium; Chelating Agents; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; In Vitro Techniques; Mefloquine; Mice; Neuromuscular Junction; Oligomycins; Presynaptic Terminals; Thapsigargin | 2006 |